William Blair & Company
NVO

William Blair & Company’s Novo Nordisk NVO Stock Holding History

William Blair & Company’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.62M Sell
44,012
-2,258
-5% -$107K ﹤0.01% 795
2025
Q4 		$2.35M Buy
46,270
+9,982
+28% +$510K 0.01% 700
2025
Q3 		$2.01M Sell
36,288
-6,912
-16% -$405K 0.01% 725
2025
Q2 		$2.98M Sell
43,200
-5,819
-12% -$396K 0.01% 626
2025
Q1 		$3.4M Sell
49,019
-14,954
-23% -$1.24M 0.01% 582
2024
Q4 		$5.5M Sell
63,973
-15,720
-20% -$1.7M 0.02% 470
2024
Q3 		$9.49M Sell
79,693
-722
-0.9% -$96.3K 0.03% 350
2024
Q2 		$11.5M Buy
80,415
+9,379
+13% +$1.24M 0.04% 302
2024
Q1 		$9.12M Buy
71,036
+8,126
+13% +$967K 0.03% 348
2023
Q4 		$6.51M Buy
62,910
+11,948
+23% +$1.18M 0.02% 399
2023
Q3 		$4.63M Buy
50,962
+7,674
+18% +$676K 0.02% 454
2023
Q2 		$3.5M Buy
43,288
+4,732
+12% +$387K 0.01% 518
2023
Q1 		$3.07M Buy
38,556
+8,042
+26% +$570K 0.01% 550
2022
Q4 		$2.06M Sell
30,514
-10,672
-26% -$626K 0.01% 623
2022
Q3 		$2.05M Buy
41,186
+880
+2% +$47.1K 0.01% 615
2022
Q2 		$2.25M Buy
40,306
+1,374
+4% +$76.2K 0.01% 614
2022
Q1 		$2.14M Buy
38,932
+4,388
+13% +$225K 0.01% 680
2021
Q4 		$1.93M Buy
34,544
+4,046
+13% +$219K 0.01% 739
2021
Q3 		$1.46M Buy
30,498
+2,532
+9% +$122K 0.01% 786
2021
Q2 		$1.17M Sell
27,966
-4,804
-15% -$186K ﹤0.01% 871
2021
Q1 		$1.1M Sell
32,770
-6,592
-17% -$235K ﹤0.01% 868
2020
Q4 		$1.38M Sell
39,362
-7,536
-16% -$260K 0.01% 758
2020
Q3 		$1.63M Buy
46,898
+1,308
+3% +$43.6K 0.01% 635
2020
Q2 		$1.49M Sell
45,590
-1,068
-2% -$34.1K 0.01% 625
2020
Q1 		$1.4M Buy
46,658
+1,736
+4% +$51.7K 0.01% 591
2019
Q4 		$1.3M Buy
44,922
+15,480
+53% +$429K 0.01% 714
2019
Q3 		$761K Sell
29,442
-4,736
-14% -$120K ﹤0.01% 822
2019
Q2 		$872K Sell
34,178
-2,820
-8% -$69.7K 0.01% 798
2019
Q1 		$968K Buy
36,998
+4,866
+15% +$120K 0.01% 739
2018
Q4 		$740K Sell
32,132
-289,070
-90% -$6.42M 0.01% 783
2018
Q3 		$7.57M Buy
321,202
+27,706
+9% +$676K 0.05% 298
2018
Q2 		$6.77M Sell
293,496
-100,318
-25% -$2.38M 0.05% 297
2018
Q1 		$9.7M Sell
393,814
-3,872
-1% -$102K 0.07% 242
2017
Q4 		$10.7M Buy
397,686
+32,936
+9% +$838K 0.07% 243
2017
Q3 		$8.78M Buy
364,750
+138,978
+62% +$3.14M 0.07% 248
2017
Q2 		$4.84M Buy
225,772
+169,896
+304% +$3.43M 0.04% 348
2017
Q1 		$976K Buy
55,876
+24,770
+80% +$431K 0.01% 717
2016
Q4 		$558K Sell
31,106
-495,158
-94% -$8.98M 0.01% 800
2016
Q3 		$10.9M Sell
526,264
-20,896
-4% -$518K 0.1% 207
2016
Q2 		$14.7M Buy
547,160
+9,736
+2% +$267K 0.14% 171
2016
Q1 		$14.6M Sell
537,424
-4,802
-0.9% -$129K 0.14% 168
2015
Q4 		$15.7M Buy
542,226
+32,272
+6% +$893K 0.15% 153
2015
Q3 		$13.8M Sell
509,954
-8,730
-2% -$247K 0.12% 188
2015
Q2 		$14.2M Buy
518,684
+3,154
+0.6% +$88.7K 0.02% 772
2015
Q1 		$13.8M Sell
515,530
-154,202
-23% -$3.55M 0.02% 749
2014
Q4 		$14.2M Sell
669,732
-58,090
-8% -$1.3M 0.02% 718
2014
Q3 		$17.3M Sell
727,822
-812
-0.1% -$18.7K 0.03% 625
2014
Q2 		$16.8M Sell
728,634
-90,248
-11% -$1.99M 0.03% 634
2014
Q1 		$18.7M Sell
818,882
-7,538
-0.9% -$161K 0.03% 575
2013
Q4 		$15.3M Sell
826,420
-86,270
-9% -$1.5M 0.03% 636
2013
Q3 		$15.4M Sell
912,690
-590
-0.1% -$9.92K 0.03% 587
2013
Q2 		$14.2M Buy
+913,280
New +$15.2M 0.03% 584

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

William Blair & Company's NVO Position: Q1 2026 in Review

William Blair & Company reduced its Novo Nordisk (NVO) stake by 4.9% in Q1 2026, selling an estimated $107K and leaving 44,012 shares worth $1.62M. The position accounts for ﹤0.01% of the portfolio, ranked #795.

William Blair & Company first reported a position in NVO in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.7M in Q1 2014. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • William Blair & Company held 44,012 shares of Novo Nordisk worth $1.62M as of Q1 2026.
  • William Blair & Company sold 2,258 Novo Nordisk shares in Q1 2026, an estimated $107K.
  • Novo Nordisk made up ﹤0.01% of William Blair & Company's portfolio in Q1 2026, its #795 holding.
  • William Blair & Company first reported a position in Novo Nordisk in Q2 2013 and has held it in 52 quarters since.
  • William Blair & Company's Novo Nordisk position peaked at $18.7M in Q1 2014.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.